1. Home
  2. INZY vs SMHI Comparison

INZY vs SMHI Comparison

Compare INZY & SMHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INZY
  • SMHI
  • Stock Information
  • Founded
  • INZY 2015
  • SMHI 1989
  • Country
  • INZY United States
  • SMHI United States
  • Employees
  • INZY N/A
  • SMHI N/A
  • Industry
  • INZY Biotechnology: Pharmaceutical Preparations
  • SMHI Marine Transportation
  • Sector
  • INZY Health Care
  • SMHI Consumer Discretionary
  • Exchange
  • INZY Nasdaq
  • SMHI Nasdaq
  • Market Cap
  • INZY 256.3M
  • SMHI 139.9M
  • IPO Year
  • INZY 2020
  • SMHI N/A
  • Fundamental
  • Price
  • INZY N/A
  • SMHI $5.63
  • Analyst Decision
  • INZY Buy
  • SMHI
  • Analyst Count
  • INZY 9
  • SMHI 0
  • Target Price
  • INZY $15.22
  • SMHI N/A
  • AVG Volume (30 Days)
  • INZY 989.2K
  • SMHI 122.9K
  • Earning Date
  • INZY 08-05-2025
  • SMHI 07-30-2025
  • Dividend Yield
  • INZY N/A
  • SMHI N/A
  • EPS Growth
  • INZY N/A
  • SMHI N/A
  • EPS
  • INZY N/A
  • SMHI N/A
  • Revenue
  • INZY N/A
  • SMHI $264,089,999.00
  • Revenue This Year
  • INZY N/A
  • SMHI N/A
  • Revenue Next Year
  • INZY N/A
  • SMHI $11.59
  • P/E Ratio
  • INZY N/A
  • SMHI N/A
  • Revenue Growth
  • INZY N/A
  • SMHI N/A
  • 52 Week Low
  • INZY $0.72
  • SMHI $3.63
  • 52 Week High
  • INZY $6.24
  • SMHI $15.36
  • Technical
  • Relative Strength Index (RSI)
  • INZY 82.67
  • SMHI 49.61
  • Support Level
  • INZY $3.94
  • SMHI $4.94
  • Resistance Level
  • INZY $3.97
  • SMHI $5.42
  • Average True Range (ATR)
  • INZY 0.01
  • SMHI 0.30
  • MACD
  • INZY -0.08
  • SMHI -0.06
  • Stochastic Oscillator
  • INZY 100.00
  • SMHI 33.15

About INZY Inozyme Pharma Inc.

Inozyme Pharma Inc is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting bone health and blood vessel function. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. Its product candidate, INZ-701, is a soluble, recombinant, genetically engineered fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 deficiencies.

About SMHI SEACOR Marine Holdings Inc.

Seacor Marine Holdings Inc provides marine and support transportation services to offshore energy facilities globally. The company operates and manages a diverse fleet of offshore support vessels that deliver cargo and personnel to offshore installations, including wind farms, handle anchors, and mooring equipment for offshore rigs and platforms. Its geographical segment includes the United States (Gulf of Mexico), Africa and Europe, Middle East and Asia, and Latin America.

Share on Social Networks: